Two active ingredients found in a number of non-prescription cough medicines are no better than non-medicated syrup for children with upper respiratory tract infections, says a Penn State College of Medicine study. “Consumers spend billions of dollars each year on over-the-counter medications for cough,” said Ian Paul, of the Penn State Milton S. Hershey Medical Center. “Our study showed that the two ingredients used in most over-the-counter medications were no better than a placebo, non-medicated syrup, in providing nighttime relief for children with cough and sleep difficulty as a result of upper respiratory infection.” The study appeared in the journal Pediatrics.
Study volunteers, aged from two to eighteen with upper respiratory infections, were recruited from two practices affiliated with Penn State Hershey Medical Center. Symptoms, as reported from the parents, had to reach a certain threshold for children to be admitted to the study. Then, each child was randomly assigned to receive dextromethorphan (often abbreviated as “DM”), diphenhydramine (an over-the-counter antihistamine) or placebo. Of the children with upper respiratory infections included in the study, 33% patients received dextromethorphan, 33% received diphenhydramine and 34% received placebo. Patients were ill an average of 4.21 days before participation in the study. The symptom scores from the night before treatment were compared to those after treatment.
Not only was there no significant improvement for the children who took cough medicines with the active ingredients, but in the cough frequency category, those who received placebo reported a 2.24 point improvement in cough frequency, whereas the parents of those who took the medicines with active ingredients reported only a 1.97 point improvement.